Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target among analysts […]
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average […]
NovoCure (NASDAQ:NVCR – Free Report) had its target price trimmed by Wells Fargo & Company from $49.00 to $42.00 in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical equipment provider’s stock. Other analysts have also recently issued research reports about the company. HC Wainwright upped […]
NovoCure (NASDAQ: NVCR) has recently received a number of price target changes and ratings updates: 4/3/2024 – NovoCure had its price target lowered by analysts at Wells Fargo & Company from $49.00 to $42.00. They now have an “overweight” rating on the stock. 3/27/2024 – NovoCure had its “neutral” rating reaffirmed by analysts at Wedbush. […]
NovoCure (NASDAQ:NVCR – Get Free Report) had its target price lowered by investment analysts at Wells Fargo & Company from $49.00 to $42.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price objective indicates a potential upside […]